CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shenzhen Neptunus Interlong Bio-technique Co Ltd Company Snapshot
Shenzhen Neptunus Interlong Bio-technique Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Neptunus Interlong Bio-technique Co Ltd with three other companies in this sector in China: Ginwa Enterprise Group Inc. (2017 sales of 756.60 million Chinese Renmimbi [US$110.50 million] of which 74% was Pharmaceutical Industry), Zhejiang Jolly Pharmaceutical Co Ltd (793.91 million Chinese Renmimbi [US$115.95 million] of which 75% was Medicinal), and Wuhan Hiteck Biological Pharma Co Ltd (750.26 million Chinese Renmimbi [US$109.58 million] of which 99% was Medicine Manufacture).

Sales Analysis. During the year ended December of 2017, sales at Shenzhen Neptunus Interlong Bio-technique Co Ltd were 790.29 million Chinese Renmimbi (US$115.42 million). This is an increase of 4.1% versus 2016, when the company's sales were 759.11 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shenzhen Neptunus Interlong Bio-technique Co Ltd (and since 2012, sales have increased a total of 49%). Sales of Purchase and Sales of Medicines and Health saw an increase that was more than double the company's growth rate: sales were up 10.7% in 2017, from 328.07 million Chinese Renmimbi to 363.26 million Chinese Renmimbi. Not all segments of Shenzhen Neptunus Interlong Bio-technique Co Ltd experienced an increase in sales in 2017: sales of Manufacturing and Selling Medicine Products fell 0.9% to 427.02 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shenzhen Neptunus Interlong Bio-technique Co Ltd
  Stock Performance Chart for Shenzhen Neptunus Interlong Bio-technique Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): .33
(Figures in Chinese Renmimbi)
1 Week 0.1%   13 Weeks 2.2%  
4 Weeks 17.3%   52 Weeks 2.3%  
 
Shenzhen Neptunus Interlong Bio-technique Co Ltd Key Data:
  Ticker: 8329 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 790,286,000
(Year Ending Jan 2018).
Employees: 1,231
  Currency: Chinese Renmimbi Market Cap: 555,686,480
  Fiscal Yr Ends: December Shares Outstanding: 1,678,000,000
  Share Type: H Gu Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.